Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study
…, Y Yuan, J Chen, S Qin, R Jia, M Lu, Y Cheng… - The Lancet …, 2020 - thelancet.com
Background Surufatinib showed superior efficacy in extrapancreatic neuroendocrine tumours
(NETs) in the phase 3 SANET-ep study. In SANET-p, we aimed to assess the efficacy and …
(NETs) in the phase 3 SANET-ep study. In SANET-p, we aimed to assess the efficacy and …
Safety, pharmacokinetics, and dosimetry of a long-acting radiolabeled somatostatin analog 177Lu-DOTA-EB-TATE in patients with advanced metastatic …
J Zhang, H Wang, O Jacobson, Y Cheng… - Journal of Nuclear …, 2018 - Soc Nuclear Med
Radiolabeled somatostatin analog therapy has become an established treatment method
for patients with well to moderately differentiated unresectable or metastatic neuroendocrine …
for patients with well to moderately differentiated unresectable or metastatic neuroendocrine …
Surufatinib in advanced well-differentiated neuroendocrine tumors: a multicenter, single-arm, open-label, phase Ib/II trial
…, R Jia, M Lu, Y Cheng, C Mao, W Wang, K Cheng… - Clinical cancer …, 2019 - AACR
Purpose: No antiangiogenic treatment is yet approved for extrapancreatic neuroendocrine
tumors (NET). Surufatinib (HMPL-012, previously named sulfatinib) is a small-molecule …
tumors (NET). Surufatinib (HMPL-012, previously named sulfatinib) is a small-molecule …
Head-to-head comparison of 68Ga-DOTA-JR11 and 68Ga-DOTATATE PET/CT in patients with metastatic, well-differentiated neuroendocrine tumors: a prospective …
W Zhu, Y Cheng, X Wang, S Yao, C Bai… - Journal of Nuclear …, 2020 - Soc Nuclear Med
68 Ga-DOTA-JR11 is a somatostatin receptor subtype 2–specific antagonist used for PET/CT
imaging. The purpose of this study was to compare 68 Ga-DOTA-JR11 and 68 Ga-…
imaging. The purpose of this study was to compare 68 Ga-DOTA-JR11 and 68 Ga-…
[HTML][HTML] Complete genome sequence of industrial biocontrol strain Paenibacillus polymyxa HY96-2 and further analysis of its biocontrol mechanism
Y Luo, Y Cheng, J Yi, Z Zhang, Q Luo… - Frontiers in …, 2018 - frontiersin.org
Paenibacillus polymyxa (formerly known as Bacillus polymyxa) has been extensively studied
for agricultural applications as a plant-growth-promoting rhizobacterium and is also an …
for agricultural applications as a plant-growth-promoting rhizobacterium and is also an …
A prospective, randomized, double-blind study to evaluate the safety, biodistribution, and dosimetry of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in patients with well …
W Zhu, Y Cheng, R Jia, H Zhao, C Bai… - Journal of Nuclear …, 2021 - Soc Nuclear Med
68 Ga-NODAGA-LM3 (where LM3 is p-Cl-Phe-cyclo(d-Cys-Tyr-d-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)d-Tyr-NH
2 ) and 68 Ga-DOTA-LM3 are somatostatin receptor subtype 2 (SSTR2…
2 ) and 68 Ga-DOTA-LM3 are somatostatin receptor subtype 2 (SSTR2…
A prospective randomized, double-blind study to evaluate the diagnostic efficacy of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in patients with well-differentiated …
W Zhu, R Jia, Q Yang, Y Cheng, H Zhao, C Bai… - European Journal of …, 2022 - Springer
Purpose The purpose of this study is to evaluate the diagnostic efficacy of 68 Ga-NODAGA-LM3
and 68 Ga-DOTA-LM3 and compare them with 68 Ga-DOTATATE in patients with well-…
and 68 Ga-DOTA-LM3 and compare them with 68 Ga-DOTATATE in patients with well-…
Peptide receptor radionuclide therapy of late-stage neuroendocrine tumor patients with multiple cycles of 177Lu-DOTA-EB-TATE
This study aimed to evaluate the safety and efficacy of multiple cycles of 177 Lu-DOTA-Evans
blue (EB)-TATE peptide receptor radionuclide therapy (PRRT) at escalating doses in …
blue (EB)-TATE peptide receptor radionuclide therapy (PRRT) at escalating doses in …
[HTML][HTML] Serial monitoring of circulating tumor DNA in patients with metastatic colorectal cancer to predict the therapeutic response
N Jia, Z Sun, X Gao, Y Cheng, Y Zhou, C Shen… - Frontiers in …, 2019 - frontiersin.org
Early biomarkers of therapeutic responses can help optimize the treatment of metastatic
colorectal cancers (mCRC). In this prospective exploratory study, we examined serial changes …
colorectal cancers (mCRC). In this prospective exploratory study, we examined serial changes …
The impact of Paenibacillus polymyxa HY96-2 luxS on biofilm formation and control of tomato bacterial wilt
J Yi, D Zhang, Y Cheng, J Tan, Y Luo - Applied microbiology and …, 2019 - Springer
The focus of this study was to investigate the effects of luxS, a key regulatory gene of the
autoinducer-2 (AI-2) quorum sensing (QS) system, on the biofilm formation and biocontrol …
autoinducer-2 (AI-2) quorum sensing (QS) system, on the biofilm formation and biocontrol …
